Cargando…

mRNA- and Adenovirus-Based Vaccines against SARS-CoV-2 in HIV-Positive People

About two years have passed since the identification of SARS-CoV-2 in China. The rapid spread of this virus all over the world and its high transmissibility and pathogenicity in humans have resulted in a global pandemic. The negative impact of COVID-19 on health, society and the economy at the globa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garbuglia, Anna Rosa, Minosse, Claudia, Del Porto, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031858/ https://www.ncbi.nlm.nih.gov/pubmed/35458478 http://dx.doi.org/10.3390/v14040748

Ejemplares similares

Human Papillomavirus Infections in Cervical Samples From HIV-Positive Women: Evaluation of the Presence of the Nonavalent HPV Genotypes and Genetic Diversity
por: Sias, Catia, et al.
Publicado: (2020)

Torquetenovirus Loads in Peripheral Blood Predict Both the Humoral and Cell-Mediated Responses to SARS-CoV-2 Elicited by the mRNA Vaccine in Liver Transplant Recipients
por: Minosse, Claudia, et al.
Publicado: (2023)

Clinical Relevance of Torque Teno Virus (TTV) in HIV/HCV Coinfected and HCV Monoinfected Patients Treated with Direct-Acting Antiviral Therapy
por: Lapa, Daniele, et al.
Publicado: (2021)

Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV
por: Vergori, Alessandra, et al.
Publicado: (2022)

Detection of SARS-CoV-2 Variants via Different Diagnostics Assays Based on Single-Nucleotide Polymorphism Analysis
por: Specchiarello, Eliana, et al.
Publicado: (2023)

Humoral Responses Elicited by SARS-CoV-2 mRNA Vaccine in People Living with HIV
por: Marchitto, Lorie, et al.
Publicado: (2023)

B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV
por: Polvere, Jacopo, et al.
Publicado: (2023)

Origin of HAV strains responsible for 2016–2017 outbreak among MSM: Viral phylodynamics in Lazio region
por: Minosse, Claudia, et al.
Publicado: (2020)

Positive aspects of the mRNA platform for SARS-CoV-2 vaccines
por: Hajissa, Khalid, et al.
Publicado: (2021)

Hepatitis C Virus Genetic Variability, Human Immune Response, and Genome Polymorphisms: Which Is the Interplay?
por: Lapa, Daniele, et al.
Publicado: (2019)

Opposite Effects of mRNA-Based and Adenovirus-Vectored SARS-CoV-2 Vaccines on Regulatory T Cells: A Pilot Study
por: La Gualana, Francesca, et al.
Publicado: (2023)

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
por: Jackson, Lisa A., et al.
Publicado: (2020)

Symptomology following mRNA vaccination against SARS-CoV-2
por: Ebinger, Joseph E., et al.
Publicado: (2021)

mRNA Vaccines against SARS-CoV-2: Advantages and Caveats
por: Echaide, Miriam, et al.
Publicado: (2023)

The Safety and Effectiveness of mRNA Vaccines Against SARS-CoV-2
por: Jamous, Yahya F, et al.
Publicado: (2023)

Immunogenicity of an Additional mRNA-1273 SARS-CoV-2 Vaccination in People With HIV With Hyporesponse After Primary Vaccination
por: Jongkees, Marlou J, et al.
Publicado: (2022)

Ultra-Deep Sequencing Characterization of HCV Samples with Equivocal Typing Results Determined with a Commercial Assay
por: Minosse, Claudia, et al.
Publicado: (2016)

Adenovirus vector and mRNA vaccines: Mechanisms regulating their immunogenicity
por: Provine, Nicholas M., et al.
Publicado: (2022)

The Use of Both Therapeutic and Prophylactic Vaccines in the Therapy of Papillomavirus Disease
por: Garbuglia, Anna Rosa, et al.
Publicado: (2020)

Development of Bivalent mRNA Vaccines against SARS-CoV-2 Variants
por: Li, Jianglong, et al.
Publicado: (2022)

Safety of mRNA-based vaccines against SARS-CoV-2 in people with cystic fibrosis aged 12 years and over
por: Alicandro, Gianfranco, et al.
Publicado: (2022)

mRNA-1273 Protects against SARS-CoV-2 Beta Infection in Nonhuman Primates
por: Corbett, Kizzmekia S., et al.
Publicado: (2021)

An Immunological Review of SARS-CoV-2 Infection and Vaccine Serology: Innate and Adaptive Responses to mRNA, Adenovirus, Inactivated and Protein Subunit Vaccines
por: Al-Sheboul, Suhaila A., et al.
Publicado: (2022)

Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
por: Corbett, Kizzmekia S., et al.
Publicado: (2020)

Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants
por: Choi, Angela, et al.
Publicado: (2021)

Scleroderma renal crisis following mRNA vaccination against SARS-CoV-2
por: Oniszczuk, Julie, et al.
Publicado: (2021)

Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variants
por: Pegu, Amarendra, et al.
Publicado: (2021)

Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants
por: Tseng, Hung Fu, et al.
Publicado: (2022)

Respiratory mucosal immunity against SARS-CoV-2 following mRNA vaccination
por: Tang, Jinyi, et al.
Publicado: (2022)

Delayed skin reactions and mRNA vaccines against SARS-CoV-2: correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Longitudinal monitoring of mRNA-vaccine-induced immunity against SARS-CoV-2
por: Monzon-Posadas, Werner O., et al.
Publicado: (2023)

A novel mRNA vaccine, SYS6006, against SARS-CoV-2
por: Xu, Ke, et al.
Publicado: (2023)

Bivalent mRNA vaccine effectiveness against SARS-CoV-2 variants of concern
por: Kumari, Monika, et al.
Publicado: (2023)

Insights from the Construction of Adenovirus-Based Vaccine Candidates against SARS-CoV-2: Expecting the Unexpected
por: Weklak, Denice, et al.
Publicado: (2023)

Immunogenicity of BNT162b2 mRNA-Based Vaccine against SARS-CoV-2 in People with Cystic Fibrosis According to Disease Characteristics and Maintenance Therapies
por: Alicandro, Gianfranco, et al.
Publicado: (2022)

Cysteamine exerts in vitro antiviral activity against the SARS-CoV-2 Delta and Omicron variants
por: Alonzi, Tonino, et al.
Publicado: (2022)

Prospects of Replication-Deficient Adenovirus Based Vaccine Development against SARS-CoV-2
por: Garofalo, Mariangela, et al.
Publicado: (2020)

Analysis of Neutralization Titers against SARS-CoV-2 in Health-Care Workers Vaccinated with Prime-Boost mRNA–mRNA or Vector–mRNA COVID-19 Vaccines
por: Sølund, Christina, et al.
Publicado: (2022)

Quality of T-Cell Response to SARS-CoV-2 mRNA Vaccine in ART-Treated PLWH
por: Tortellini, Eeva, et al.
Publicado: (2022)

Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approach
por: Ahammad, Ishtiaque, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i5t8p3hinhd3v10pvhei536s78